Showing results (131-140 of 240) with videos related to
Sort By:
Pageof 24
Cancer|August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubationDaniela Cilloni, Francesca Messa, Enrico Gottardi, et al.Experimental Hematology|June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationSara Pozzi, Daniela Lisini, Marina Podestà, et al.Oncotarget|June 15, 2018
<i>CHL1</i> gene acts as a tumor suppressor in human neuroblastomaMarzia Ognibene, Gabriella Pagnan, Danilo Marimpietri, et al.Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.Cell Transplantation|February 3, 2009
Mesenchymal stem cells protective effect in adriamycin model of nephropathyAlberto Magnasco, Mirko Corselli, Roberta Bertelli, et al.BMC Immunology|October 4, 2014
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantationMarilena Gregorini, Francesca Bosio, Chiara Rocca, et al.Journal of Clinical Medicine|August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA SurveyMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.British Journal of Haematology|July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinibElena Crisà, Daniela Cilloni, Elena M Elli, et al.Blood|April 12, 2003
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsSebastian Giebel, Franco Locatelli, Teresa Lamparelli, et al.Pageof 24